M5V Stock Chart & Stats
€1.16
-€0.05(-3.72%)
At close: 4:00 PM EDT
€1.16
-€0.05(-3.72%)
Day’s Range― - ―
52-Week Range€1.08 - €4.79
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€37.69M
Enterprise Value€456.46
Total Cash (Recent Filing)€110.81M
Total Debt (Recent Filing)€133.20M
Price to Earnings (P/E)―
Beta0.53
Next Earnings
Aug 04, 2026EPS Estimate
-0.73Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.63
Shares Outstanding31,741,018
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.19
Price to Book (P/B)0.14
Price to Sales (P/S)0.25
P/FCF Ratio-3.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€2.34Price Target Upside102.13% Upside
Rating ConsensusHold
Number of Analyst Covering5
EPS Forecast (FY)0.49
Revenue Forecast (FY)€375.37M
Bulls Say, Bears Say
Bulls Say
Improved Medicare Unit EconomicsSustained improvement in Medicare LTV-to-CAC and wider Medicare gross margins indicate the company is acquiring higher-value members and extracting more profit per enrollment. This durable uplift in unit economics supports recurring commission revenue and margin expansion over the next 2–3 years as cohorts renew.
Fixed Cost ReductionsA material fixed-cost cut reduces the structural cost base and increases operating leverage, making future revenue growth more accretive to margins. These permanent expense actions strengthen the path to operating cash-flow breakeven and improve resilience to enrollment volatility over the medium term.
Strong Cash Buffer And Commission ReceivablesA sizable cash balance plus a growing commission receivable pipeline provide runway to fund the bridge year and invest in retention/cross-sell initiatives. The large receivable base represents a durable, realizable stream of carrier commissions that can translate to future cash receipts if collection and persistency hold.
Bears Say
Negative Operating And Free Cash FlowPersistent negative operating and free cash flow across multiple periods is a fundamental weakness, increasing funding risk and reducing margin of safety. Until OCF turns sustainably positive, reported earnings are lower quality and the company will remain reliant on cash reserves or financing to execute its multi‑year plan.
Deliberate Volume Pullback And Revenue DeclineThe intentional reduction in acquisition volume and consequent 22% revenue decline impairs scale benefits, shrinks the renewal base and reduces future commission tail. Restoring durable top-line growth without reversing improved unit economics is a multi-quarter challenge that constrains margins and cash generation.
Modest Returns And Rising LeverageLow ROE and a rising debt ratio limit capital efficiency and the company’s ability to fund growth organically. Modest returns increase sensitivity to margin pressure and make it harder to materially scale profitability without higher leverage or dilution, raising structural execution risk over the medium term.
Ehealth News
M5V FAQ
What was Ehealth’s price range in the past 12 months?
Ehealth lowest stock price was €1.08 and its highest was €4.79 in the past 12 months.
What is Ehealth’s market cap?
Ehealth’s market cap is €37.69M.
When is Ehealth’s upcoming earnings report date?
Ehealth’s upcoming earnings report date is Aug 04, 2026 which is in 5 days.
How were Ehealth’s earnings last quarter?
Ehealth released its earnings results on May 06, 2026. The company reported -€0.265 earnings per share for the quarter, missing the consensus estimate of -€0.175 by -€0.09.
Is Ehealth overvalued?
According to Wall Street analysts Ehealth’s price is currently Undervalued.
Does Ehealth pay dividends?
Ehealth does not currently pay dividends.
What is Ehealth’s EPS estimate?
Ehealth’s EPS estimate is -0.73.
How many shares outstanding does Ehealth have?
Ehealth has 31,741,018 shares outstanding.
What happened to Ehealth’s price movement after its last earnings report?
Ehealth reported an EPS of -€0.265 in its last earnings report, missing expectations of -€0.175. Following the earnings report the stock price went down -7.229%.
Which hedge fund is a major shareholder of Ehealth?
Currently, no hedge funds are holding shares in DE:M5V
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ehealth Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€2.34 (102.13% Upside)
€2.34 (102.13% Upside)
Blogger Sentiment
Bullish
DE:M5V Sentiment 70%
Sector Average ―
Sector Average ―
Technicals
SMA
Negative
20 days / 200 days
Momentum
-64.58%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
5.62%
Trailing 12-Months
Company Description
Ehealth
eHealth, Inc. operates a digital health insurance marketplace within the United States, dedicated to engaging consumers, educating them, and simplifying the health insurance enrollment process. Its operations are categorized into two main divisions: Medicare offerings, and policies tailored for individuals, families, and small enterprises. Through its sophisticated digital platforms, eHealth organizes and presents comprehensive health insurance data, empowering individuals, families, and small businesses to thoroughly research, analyze, compare, and ultimately acquire a diverse range of health insurance plans. This online marketplace grants consumers access to a vast array of insurance products from various health carriers. These include options such as Medicare Advantage, Medicare Supplement, Part D prescription drug plans, individual and family coverage, small business policies, and various ancillary health insurance products. The company promotes these health plans across its proprietary web platforms, such as eHealth.com and Medicare.com, alongside engaging with a network of strategic marketing partners. Beyond its primary marketplace functions, eHealth, Inc. also licenses its unique e-commerce technology to health insurance providers, facilitating their online marketing and distribution efforts. Furthermore, it provides services including digital sponsorship, advertising placements, and lead generation. Founded in 1997, eHealth, Inc. maintains its headquarters in Santa Clara, California.
M5V Company Deck
M5V Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call balanced near-term execution challenges with clear progress on unit economics, cost reductions and strategic product/operating-model initiatives. While revenue and submissions declined materially year-over-year and GAAP results swung to a loss due to restructuring and timing, management highlighted improved Medicare LTV-to-CAC (1.4x, +17%), wider Medicare gross margins (34% to 41%), reduced marketing spend with lower CAC, a positive adjusted EBITDA ($9M) and a plan to achieve breakeven free cash flow in 2027. The team framed 2026 as an intentional, cash-flow-focused bridge year and provided a 3-year outlook targeting margin expansion and revenue growth, supported by the lifetime advisory model and ancillary product cross-sell. On balance, the operational improvements, cost actions and a credible multi-year plan offset the near-term declines.View all DE:M5V earnings summariesM5V Stock 12 Month Forecast
Average Price Target
€2.34
▲(102.13% Upside)